πŸ‡ΊπŸ‡Έ FDA
Patent

US 9616060

Particulate materials

granted A61KA61K31/4985A61K47/06

Quick answer

US patent 9616060 (Particulate materials) held by Nektar Therapeutics expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/4985, A61K47/06, A61K47/08, A61K9/008